Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
prednisolone + prednisone + methylprednisolone
- Development stage
- Unknown
- Lead developer
- Bayer HealthCare Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral, Intravenous, Intramuscular, Intraarticular, Soft Tissue Injection
01
Overview
This is a combination of three corticosteroid medications (prednisolone, prednisone, and methylprednisolone) that reduce inflammation and suppress the immune system. They work by modifying glucocorticoid receptors and suppressing mediators of inflammation. Methylprednisolone is slightly more potent than prednisone, with methylprednisolone being five times as potent as cortisol, while prednisone is four times as potent. These medications are used to treat various inflammatory and autoimmune conditions including rheumatoid arthritis, lupus, allergic reactions, asthma, and other disorders.
- Brand names
- Depo-MedrolPrelone
02
Targets
GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on prednisolone + prednisone + methylprednisolone.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on prednisolone + prednisone + methylprednisolone.